New York Nursing Homes in Crisis During COVID-19 Pandemic
On Mar. 25, 2020, New York Governor Andrew Cuomo issued an order requiring nursing homes to accept on an expedited basis all new or returning residents with confirmed or presumed COVID-19 who are discharged from the hospital after being diagnosed as medically stable. The order states: No resident shall be denied re-admission or admission to […]
Oxford Begins COVID-19 Vaccine Trials to Meet September Deadline
On Mar. 17, 2020, European Commission (EC) president Ursula von der Leyen said she was hopeful a vaccine for COVID-19 could be available this September. Her view was based on conversations she had had with managers of German biotechnology firm CureVac AG which has developed an experimental messenger RNA (mRNA) vaccine that it plans to […]
COVID-19 Meltdown and Pharma’s Big Money Win
Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases (NIAID) told Americans on Apr. 1, 2020 that modeling reports suggested COVID-19 infections could eventually “kill 100,000 to 240,000 Americans,”1 2 3 which was considerably less than the worst case 1.7 million mortality figure the Centers for Disease Control and Prevention (CDC) […]
Mortality Rate for COVID-19 May Be Closer to Influenza
At a press briefing on Mar. 3, 2020, the director general of the World Health Organization (WHO), Dr. Tedros Ghebreyesus, said, “Globally, about 3.4 percent of reported COVID-19 cases have died.” On Mar. 13, The New York Times reported that modeling experts from the Centers for Disease Control and Prevention (CDC) were estimating that if […]
HIV Vaccine Fails Clinical Trial in South Africa
Story Highlights Another attempt to create an effective vaccine against the Human Immunodeficiency Virus (HIV) has been stopped early because it was not found to prevent HIV infection. It is estimated that 1,000 people are newly infected every day in South Africa. HIV virus appears to evade and destroy cells of the immune system and […]
Fluzone Quadrivalent Influenza Vaccine Approved by FDA for Elderly
The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (BLA) for the Fluzone high-dose quadrivalent influenza vaccine for use by adults 65 years of age and older. Fluzone is manufactured by Sanofi Pasteur, Inc. of France.1 2 The Fluzone high-dose influenza vaccine was approved by the FDA in 2009 as […]